The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance.

RONS Trx TrxR antioxidative defence oxidative stress resistance to therapy

Journal

Frontiers in molecular biosciences
ISSN: 2296-889X
Titre abrégé: Front Mol Biosci
Pays: Switzerland
ID NLM: 101653173

Informations de publication

Date de publication:
2022
Historique:
received: 24 02 2022
accepted: 22 04 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

The intracellular redox homeostasis is a dynamic balancing system between the levels of free radical species and antioxidant enzymes and small molecules at the core of cellular defense mechanisms. The thioredoxin (Trx) system is an important detoxification system regulating the redox milieu. This system is one of the key regulators of cells' proliferative potential as well, through the reduction of key proteins. Increased oxidative stress characterizes highly proliferative, metabolically hyperactive cancer cells, which are forced to mobilize antioxidant enzymes to balance the increase in free radical concentration and prevent irreversible damage and cell death. Components of the Trx system are involved in high-rate proliferation and activation of pro-survival mechanisms in cancer cells, particularly those facing increased oxidative stress. This review addresses the importance of the targetable redox-regulating Trx system in tumor progression, as well as in detoxification and protection of cancer cells from oxidative stress and drug-induced cytotoxicity. It also discusses the cancer cells' counteracting mechanisms to the Trx system inhibition and presents several inhibitors of the Trx system as prospective candidates for cytostatics' adjuvants. This manuscript further emphasizes the importance of developing novel multitarget therapies encompassing the Trx system inhibition to overcome cancer treatment limitations.

Identifiants

pubmed: 35664671
doi: 10.3389/fmolb.2022.883297
pii: 883297
pmc: PMC9161637
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

883297

Informations de copyright

Copyright © 2022 Jovanović, Podolski-Renić, Krasavin and Pešić.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Mol Clin Oncol. 2017 Feb;6(2):139-153
pubmed: 28357082
Cancer Lett. 2011 Jul 1;306(1):60-6
pubmed: 21439723
Cancer Res. 2019 Jan 1;79(1):125-132
pubmed: 30401714
Anticancer Drugs. 2011 Sep;22(8):732-40
pubmed: 21562407
Nature. 2006 Dec 7;444(7120):756-60
pubmed: 17051156
Breast Cancer (Dove Med Press). 2014 May 23;6:73-80
pubmed: 24976757
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383
pubmed: 32231263
J Cancer Prev. 2019 Jun;24(2):65-71
pubmed: 31360686
Cell Oncol (Dordr). 2019 Dec;42(6):847-860
pubmed: 31493144
Oral Oncol. 2008 Oct;44(10):963-9
pubmed: 18282784
FEBS Open Bio. 2020 Aug;10(8):1532-1541
pubmed: 32511893
Oxid Med Cell Longev. 2016;2016:6235641
pubmed: 27418953
Biochim Biophys Acta. 2013 Aug;1836(1):60-79
pubmed: 23466753
Clin Cancer Res. 2001 Jun;7(6):1750-7
pubmed: 11410516
Nutrients. 2019 Aug 16;11(8):
pubmed: 31426306
Int Rev Cell Mol Biol. 2008;270:87-144
pubmed: 19081535
Biol Chem. 2019 Apr 24;400(5):589-612
pubmed: 30352021
Cancer Res. 2004 May 15;64(10):3599-606
pubmed: 15150118
Cancer Cell. 2018 Jul 9;34(1):21-43
pubmed: 29731393
Biochem Biophys Res Commun. 2005 Feb 18;327(3):774-9
pubmed: 15649413
Oncotarget. 2015 Jun 30;6(18):16488-506
pubmed: 26029997
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Clin Oncol. 2005 Jan 20;23(3):422-31
pubmed: 15659489
Oncol Rep. 2003 Jan-Feb;10(1):39-43
pubmed: 12469142
Cytokine Growth Factor Rev. 2013 Aug;24(4):345-53
pubmed: 23403036
Trends Pharmacol Sci. 2017 Sep;38(9):794-808
pubmed: 28648527
Mol Cancer. 2014 Mar 19;13:62
pubmed: 24645981
Neurooncol Adv. 2021 Jun 24;3(1):vdab075
pubmed: 34377985
J Biol Chem. 1989 Aug 25;264(24):13963-6
pubmed: 2668278
Anticancer Res. 1996 Nov-Dec;16(6B):3459-66
pubmed: 9042207
Int J Oncol. 2014 Nov;45(5):2044-50
pubmed: 25109398
Genes Dev. 2013 Oct 15;27(20):2179-91
pubmed: 24142871
Curr Med Chem. 2019;26(33):6074-6106
pubmed: 29874992
Cancer Chemother Pharmacol. 2011 Mar;67(3):503-9
pubmed: 20461382
PLoS One. 2018 Mar 26;13(3):e0194224
pubmed: 29579058
Redox Biol. 2017 Apr;11:254-262
pubmed: 28012440
Histopathology. 2012 May;60(6):943-52
pubmed: 22348534
Turk Neurosurg. 2018;28(1):7-12
pubmed: 28345125
Oxid Med Cell Longev. 2010 Jan-Feb;3(1):23-34
pubmed: 20716925
Eur J Med Chem. 2019 Nov 1;181:111580
pubmed: 31400708
Nat Commun. 2011 Jul 12;2:383
pubmed: 21750537
Ann Otol Rhinol Laryngol. 2010 Aug;119(8):567-71
pubmed: 20860283
Radiat Res. 2016 Oct;186(4):385-395
pubmed: 27643875
Cancer Lett. 2006 May 8;236(1):46-53
pubmed: 15982805
Cold Spring Harb Symp Quant Biol. 2016;81:163-175
pubmed: 28082378
J Lab Clin Med. 2003 Jul;142(1):46-51
pubmed: 12878985
J Neurooncol. 2010 Dec;100(3):407-15
pubmed: 20446016
Nat Rev Drug Discov. 2009 Jul;8(7):579-91
pubmed: 19478820
Cell. 2010 Feb 19;140(4):454-6
pubmed: 20178737
Semin Cell Dev Biol. 2018 Aug;80:50-64
pubmed: 28587975
Drugs R D. 2015 Mar;15(1):13-20
pubmed: 25698589
J Cancer. 2020 Mar 4;11(10):3013-3019
pubmed: 32226516
Antioxid Redox Signal. 2007 Jan;9(1):25-47
pubmed: 17115886
J Clin Invest. 2016 May 2;126(5):1630-9
pubmed: 27135880
Eur J Biochem. 2001 Jan;268(2):405-13
pubmed: 11168376
Oxid Med Cell Longev. 2019 Mar 12;2019:3061607
pubmed: 30984333
Cancers (Basel). 2010 Mar 25;2(2):209-32
pubmed: 24281068
Int J Cancer. 2014 Dec 1;135(11):2569-78
pubmed: 24752463
Med Res Rev. 2004 Jan;24(1):40-89
pubmed: 14595672
Cancer Lett. 2009 Sep 8;282(1):116-23
pubmed: 19345479
Leukemia. 2006 Aug;20(8):1400-7
pubmed: 16728981
BMC Cancer. 2019 Aug 30;19(1):865
pubmed: 31470801
Biochemistry (Mosc). 2008 Dec;73(13):1493-510
pubmed: 19216714
Cell Death Dis. 2018 Jan 24;9(2):89
pubmed: 29367724
Blood. 2001 May 15;97(10):3184-90
pubmed: 11342447
Cancer Cell. 2015 Feb 9;27(2):211-22
pubmed: 25620030
BMC Med. 2011 May 23;9:62
pubmed: 21605374
J Amino Acids. 2012;2012:736837
pubmed: 22500213
Redox Biol. 2016 Aug;8:175-85
pubmed: 26795735
J Neurochem. 2018 Jan;144(1):93-104
pubmed: 29105080
Science. 1988 Apr 29;240(4852):640-2
pubmed: 2834821
Eur J Med Chem. 2020 Apr 1;191:112119
pubmed: 32087464
Oncotarget. 2012 Mar;3(3):314-26
pubmed: 22447839
Tuberc Respir Dis (Seoul). 2013 Aug;75(2):59-66
pubmed: 24023558
Invest New Drugs. 2012 Aug;30(4):1591-6
pubmed: 21863237
J Exp Clin Cancer Res. 2019 May 21;38(1):207
pubmed: 31113439
Cancer Chemother Pharmacol. 2019 Sep;84(3):453-470
pubmed: 31079220
J Clin Invest. 1996 May 15;97(10):2268-76
pubmed: 8636406
Brain Pathol. 2003 Apr;13(2):155-64
pubmed: 12744469
Anticancer Res. 2001 Mar-Apr;21(2A):1129-33
pubmed: 11396151
J Biol Chem. 2006 May 12;281(19):13005-13008
pubmed: 16565519
Antioxid Redox Signal. 2010 Dec 1;13(11):1665-78
pubmed: 20446768
Semin Cancer Biol. 2006 Dec;16(6):420-6
pubmed: 17092741
Curr Med Chem. 2019;26(4):607-623
pubmed: 29149832
Front Mol Biosci. 2020 Oct 06;7:586146
pubmed: 33134322
Cancer Lett. 2008 Feb 18;260(1-2):96-108
pubmed: 18036733
Free Radic Biol Med. 2019 Aug 20;140:14-27
pubmed: 31201851
J Neurol Surg A Cent Eur Neurosurg. 2013 Jul;74(4):234-8
pubmed: 23512591
Nature. 2015 Nov 12;527(7577):186-91
pubmed: 26466563
Molecules. 2020 Sep 28;25(19):
pubmed: 32998355
Mol Cancer Ther. 2013 Jul;12(7):1299-309
pubmed: 23657945
Oncotarget. 2015 Jun 20;6(17):15410-24
pubmed: 25945832
Int J Cancer. 2020 Jan 1;146(1):123-136
pubmed: 31090219
Antioxid Redox Signal. 2013 Nov 1;19(13):1539-605
pubmed: 23397885
Semin Cancer Biol. 2015 Apr;31:16-27
pubmed: 24956577
J Biol Chem. 2012 Nov 2;287(45):38210-9
pubmed: 22977247
Antioxid Redox Signal. 2008 Sep;10(9):1565-76
pubmed: 18498222
Cancer Cell. 2020 Aug 10;38(2):167-197
pubmed: 32649885
Free Radic Biol Med. 2012 Mar 1;52(5):898-908
pubmed: 22210352
Free Radic Biol Med. 2019 Apr;134:190-199
pubmed: 30639567
Free Radic Biol Med. 2009 Jul 15;47(2):176-83
pubmed: 19397999
Cancers (Basel). 2019 Jul 03;11(7):
pubmed: 31277230
Proc Natl Acad Sci U S A. 2000 May 23;97(11):5854-9
pubmed: 10801974
Drug Resist Updat. 2016 May;26:1-9
pubmed: 27180306
EMBO J. 2003 Oct 15;22(20):5501-10
pubmed: 14532122
J Biol Chem. 2006 Aug 4;281(31):21884-21891
pubmed: 16766796
Biochem Pharmacol. 2002 May 15;63(10):1875-84
pubmed: 12034372
J Neurochem. 2009 May;109(4):1079-86
pubmed: 19519779
Mol Oncol. 2019 May;13(5):1180-1195
pubmed: 30861284
Cancer Res. 2013 Sep 1;73(17):5532-43
pubmed: 23824739
Clin Cancer Res. 2007 Apr 1;13(7):2109-14
pubmed: 17404093
Oncol Lett. 2017 Aug;14(2):2053-2058
pubmed: 28781647
Cancers (Basel). 2011 Mar 29;3(2):1605-21
pubmed: 24212776
Mol Cell. 2006 Mar 3;21(5):689-700
pubmed: 16507366
Antioxid Redox Signal. 2017 Jul 10;27(2):106-114
pubmed: 27733046
Eur J Cancer. 2020 Nov;140:130-139
pubmed: 33091717
Oncol Rep. 2016 Jan;35(1):546-51
pubmed: 26530353
Antioxid Redox Signal. 2009 Nov;11(11):2701-16
pubmed: 19778285
Sci Transl Med. 2014 Jan 29;6(221):221ra15
pubmed: 24477002
Redox Biol. 2018 Apr;14:237-249
pubmed: 28965082
Biochim Biophys Acta. 2015 Mar;1852(3):395-405
pubmed: 25483711
Genes Dis. 2016 May 11;3(3):198-210
pubmed: 30258889
Drug Resist Updat. 2005 Oct;8(5):322-30
pubmed: 16230045
Acta Pharmacol Sin. 2006 Aug;27(8):1078-84
pubmed: 16867262
Br J Pharmacol. 2012 Jan;165(2):289-312
pubmed: 21718296
Free Radic Biol Med. 2019 May 1;135:216-226
pubmed: 30880248
Blood Cancer J. 2016 Jul 15;6(7):e446
pubmed: 27421095
Clin Cancer Res. 2001 Oct;7(10):3087-91
pubmed: 11595699
Oncotarget. 2017 Oct 9;8(56):96062-96078
pubmed: 29221187
J Cancer Res Clin Oncol. 1999;125(6):327-35
pubmed: 10363564
Drug Resist Updat. 2018 Nov;41:1-25
pubmed: 30471641
Expert Rev Anticancer Ther. 2013 Mar;13(3):239-41
pubmed: 23477507
Antioxid Redox Signal. 2018 Mar 1;28(7):537-557
pubmed: 28587524
Mol Neurobiol. 2020 Jul;57(7):2889-2901
pubmed: 32418115
Cancer Res. 2000 Apr 15;60(8):2281-9
pubmed: 10786696
Redox Biol. 2016 Aug;8:68-78
pubmed: 26760912
PLoS One. 2012;7(10):e48175
pubmed: 23118946
J Cell Biochem. 2019 Jan;120(1):71-76
pubmed: 30203529
Cell Rep. 2018 Mar 6;22(10):2677-2689
pubmed: 29514096
Antioxid Redox Signal. 2007 Jan;9(1):49-89
pubmed: 17115887
Invest New Drugs. 2013 Jun;31(3):631-641
pubmed: 22711542
Bull Exp Biol Med. 2012 Oct;153(6):878-81
pubmed: 23113308
Clin Cancer Res. 2000 Aug;6(8):3183-92
pubmed: 10955802
Oxid Med Cell Longev. 2013;2013:972913
pubmed: 23766865
J Biol Chem. 2001 Aug 10;276(32):30542-51
pubmed: 11375392
Neuropathol Appl Neurobiol. 2001 Feb;27(1):29-39
pubmed: 11299000
Int J Mol Sci. 2018 Sep 21;19(10):
pubmed: 30248944
Drug Resist Updat. 2021 Sep;58:100778
pubmed: 34403910
J Biochem Pharmacol Res. 2013 Mar;1(1):15-26
pubmed: 23662248
Clin Cancer Res. 2005 Dec 1;11(23):8425-30
pubmed: 16322305
Oncotarget. 2016 Aug 2;7(31):50239-50257
pubmed: 27384484
Nat Chem Biol. 2018 Feb;14(2):148-155
pubmed: 29251718
Biomed Res Int. 2019 Nov 18;2019:6502793
pubmed: 31828114
Int J Mol Sci. 2021 Dec 22;23(1):
pubmed: 35008532
Hepatology. 2019 Apr;69(4):1768-1786
pubmed: 30561826
Br J Cancer. 2001 Feb;84(4):529-34
pubmed: 11207049
Oncotarget. 2016 Jan 19;7(3):3548-58
pubmed: 26657290
Biochemistry. 2009 Jul 7;48(26):6213-23
pubmed: 19366212
Antioxidants (Basel). 2019 Oct 10;8(10):
pubmed: 31658599
Front Oncol. 2020 Mar 10;10:252
pubmed: 32219063
Proc Natl Acad Sci U S A. 2019 Jun 4;116(23):11408-11417
pubmed: 31097586
Drug Des Devel Ther. 2018 Oct 23;12:3535-3547
pubmed: 30425455
Eur J Biochem. 2000 Oct;267(20):6102-9
pubmed: 11012661
Free Radic Biol Med. 2013 Dec;65:750-764
pubmed: 23820265
Cell Death Dis. 2014 Apr 24;5:e1191
pubmed: 24763048
Drug Resist Updat. 2019 Sep;46:100645
pubmed: 31585396
Antioxid Redox Signal. 2008 Nov;10(11):1941-88
pubmed: 18774901
Oral Oncol. 2011 Jul;47(7):609-14
pubmed: 21652258
Biochim Biophys Acta. 2008 Nov;1780(11):1304-17
pubmed: 18621099
Cancers (Basel). 2019 Jun 05;11(6):
pubmed: 31195711
Autophagy. 2014 Jul;10(7):1241-55
pubmed: 24905460
Biochem Pharmacol. 2019 Dec;170:113642
pubmed: 31541631
Trends Biochem Sci. 2009 Apr;34(4):176-88
pubmed: 19321346
Cancer Res. 1992 Dec 15;52(24):6885-9
pubmed: 1458477
Free Radic Biol Med. 2012 Jan 15;52(2):257-65
pubmed: 22064364
Curr Pharm Des. 2018;24(36):4334-4354
pubmed: 30648503
Br J Radiol. 2014 Mar;87(1035):20130676
pubmed: 24588669
Semin Cancer Biol. 2006 Dec;16(6):427-35
pubmed: 17081769
Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13227-32
pubmed: 15328416
Free Radic Biol Med. 2017 Mar;104:144-164
pubmed: 28088622
Biochem Biophys Res Commun. 2010 May 21;396(1):120-4
pubmed: 20494123

Auteurs

Mirna Jovanović (M)

Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Ana Podolski-Renić (A)

Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Mikhail Krasavin (M)

Organic Chemistry Division, Institute of Chemistry, Saint Petersburg State University, Saint Petersburg, Russia.

Milica Pešić (M)

Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Classifications MeSH